Attributing His Death to the Use of Remdesivir to Treat COVID-19, a Veteran’s Spouse Continues to Search for Answers
Attributing His Death to the Use of Remdesivir to Treat COVID-19, a Veteran’s Spouse Continues to Search for Answers
April 2, 2025
After discovering whistleblower data about the deaths of 19 service members who were treated with remdesivir for COVID-19 at Eglin Air Force Base, Sharon Burns reached out to this author to share her husband’s story.
In a previous report by The Gateway Pundit, it was revealed that across the Department of Defense (DoD) that 601 of 941 patients who died between March 2020 and March 2024 were treated with remdesivir. The data set below captures service members, retirees, and dependents, including those from Eglin AFB.
Mrs. Burns brought her husband, a retired Air Force veteran, to Eglin AFB hospital on August 3, 2020, with symptoms of COVID-19.
Sadly, on August 11, 2020, Mrs. Burns lost her beloved husband of 44 years. In the years following Michael’s death, Mrs. Burns admitted that she was “living in a fog,” but now has the strength to go public with her husband’s story.
She and her husband suspected COVID-19 near the end of July 2020, she told The Gateway Pundit. With Mr. Burns’ symptoms getting worse, she drove him to the emergency room about five days later.
“While I parked our car, he walked in under his own power—but when I got to the door, they wouldn’t let me in,” she said.
After waiting outside for nearly three hours, she finally received a phone call to inform her that Mr. Burns was being admitted to the hospital.
“This day was the last time I ever saw him,” she shared.
Mrs. Burns was only able to maintain contact with her husband for the four days following his admission into the hospital, and according to him, his health improved during this time.
“They were watching him for ‘the critical days’ of five through nine,” she was told. “But on the sixth day, things were starting to look worse, [particularly with his breathing].”
“At around 7 o’clock in the morning of the ninth day, I received a phone call, informing me that my husband was going to die that day,” Mrs. Burns said. She was told that her husband was going to suffer from “a major heart attack” and that he had also agreed to a “do not resuscitate” or DNR order, as well as comfort care.
Later that same afternoon, she was informed that her 67-year-old husband, who was previously “in decent health,” passed away from respiratory failure.
“I was angry that he was alone,” she shared. “No patient should ever be alone without support or an advocate.” She likens the circumstance to an “inhumane solitary confinement.”
With regard to her husband’s death, it has been clearly determined that the use of remdesivir can result in many potential organ-based adverse effects, including respiratory failure, pneumonia, and pneumothorax.
“I started to learn about a COVID standard of care in the hospitals that was not the regular standard of care [for other respiratory illnesses],” Mrs. Burns explained, as her husband battled each of these adverse effects.
“Records show [Mr. Burns] received the standard 200 mg remdesivir on admittance, followed by 100 mg every day for eight days,” she said. Interestingly, she learned through a doctor unaffiliated with Eglin AFB that “my husband appears to have died from an untreated viral pneumonia and that a lot of information is missing from his medical records.”
Could Remdesivir’s use in the hospital’s COVID-19 treatment protocol be the cause of death for Mrs. Burns’ husband? According to her, the answer is yes. She believes the drug, with its history of lethality, contributed to her husband’s death.
Mrs. Burns pointed out that, to this day, Eglin AFB has provided very little about her husband’s medical records. She said, “My husband’s Medicine Administration Record (MAR) and the nurse’s intervention notes are missing.”
Because her husband would have been receiving a drug approved for emergency use only at the time (prior to October 22, 2020), there should have also been a signed informed consent form. Such a form has not been made available.
Mrs. Burns also questions whether there should be a signed DNR, or a record of a verbal agreement. And finally, she added, “Tricare cannot even find my husband’s billing records, which they usually keep for ten years.”
Why is Eglin AFB failing to help Mrs. Burns find the truth about her husband’s death? Did they fail to keep accurate records? Or are they hiding something, perhaps?
To learn more about service members and veterans who were treated with remdesivir and passed away, the author submitted Freedom of Information Act requests to the Department of Defense (DoD) and Department of Veterans Affairs (VA) on January 14, 2025.
These were the requested records:
- The total number of service members/veterans diagnosed and treated for COVID-19 in 2020 and 2021.
- Of those, the number who were treated with remdesivir.
- The total number of service members/veterans who died from COVID-19 in 2020 and in 2021.
- Of those service members/veterans who died, the number who were treated with remdesivir.
On March 6, the VA responded by citing two exemptions to justify withholding the information. In summary, it was suggested that personally identifiable information was requested and that the information requested does not outweigh the privacy interest of the case.
In an appeal currently under review by the VA’s Office of General Counsel, it was argued that neither of the exemptions are applicable to the information that was requested.
The FOIA request sent to DoD had an expected completion date of March 25, 2025, but the current status suggests it has only been “assigned for processing.”
Mrs. Burns encourages readers to visit the COVID-19 Humanity Betrayal Memory Project, and become active in sharing stories like her husband’s.
“We need justice,” she lamented.
The post Attributing His Death to the Use of Remdesivir to Treat COVID-19, a Veteran’s Spouse Continues to Search for Answers appeared first on The Gateway Pundit.
Go to Source
Author: J.M. Phelps
